The Impact of Supplemental Macular Carotenoids in Alzheimer's Disease: A Randomized Clinical Trial | Zendy

John M. Nolan | Zendy; Ekaterina Loskutova | Zendy; Alan Howard | Zendy; Ríona Mulcahy | Zendy; Rachel Moran | Zendy; Jim Stack | Zendy; Maggie Bolger | Zendy; Robert F. Coen | Zendy; Jessica Dennison | Zendy; Kwadwo Owusu Akuffo | Zendy; Niamh Owens | Zendy; Rebecca Power | Zendy; David I. Thurnham | Zendy; Stephen Beatty | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Impact of Supplemental Macular Carotenoids in Alzheimer's Disease: A Randomized Clinical Trial

Author(s) -

John M. Nolan,

Ekaterina Loskutova,

Alan Howard,

Ríona Mulcahy,

Rachel Moran,

Jim Stack,

Maggie Bolger,

Robert F. Coen,

Jessica Dennison,

Kwadwo Owusu Akuffo,

Niamh Owens,

Rebecca Power,

David I. Thurnham,

Stephen Beatty

Publication year - 2015

Publication title -

journal of alzheimer s disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.677

H-Index - 139

eISSN - 1875-8908

pISSN - 1387-2877

DOI - 10.3233/jad-142265

Subject(s) - cambridge neuropsychological test automated battery , lutein , zeaxanthin , macular degeneration , placebo , visual acuity , medicine , ophthalmology , randomized controlled trial , cognition , carotenoid , psychiatry , pathology , chemistry , biochemistry , alternative medicine , spatial memory , working memory

Patients with Alzheimer's disease (AD) exhibit significantly less macular pigment (MP) and poorer vision when compared to control subjects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research